Sign in to follow
Search Results

0 results for 'Arthur Cox'

You can use to get even better search results
March 08, 2001 |

SEC in Transition

At the annual Securities and Exchange Commission Speaks conference interim SEC chairwoman Laura S. Unger announced that the agency would abide by President Bush's regulatory moratorium, with no regulatory initiatives to take place until a new chairman is named and approved. Her remarks reflected a modest agenda with unassuming goals, illustrating the transitory state of the agency's leadership.
4 minute read
November 04, 2008 |

Candidates who passed the Georgia bar exam

23 minute read
March 01, 2011 |

Big Deals

Duke / Progress Energy; Alpha / Massey; AMB / Prologis; DuPont / Danisco; Qualcomm / Atheros
10 minute read
October 27, 2010 |

July 2010 Bar Exam Results

The Pennsylvania Board of Law Examiners on Oct. 8 announced the results of the bar examination given on July 27 and 28, 2010. Of the 2,027 applicants who took the examination, 1,615 passed (the overall pass rate 80%).
17 minute read
November 01, 2012 |

Deals & Suits

15 minute read
March 28, 2013 |

Big Deals

Berkshire/3G Capital/Heinz; Dell LBO; Liberty Global/Virgin Media; Zoetis IPO
10 minute read
December 01, 2009 |

Canadian Big Deals

Eldorado Gold/Sino Gold; Barrick Gold Offering; Petrobank/Tristar; Petrochina/Athabasca Oil Sands
7 minute read
October 05, 2006 |

Fosamax: The Hiding of a Public Hazard

Since the release of Merck's blockbuster drug Fosamax, there have been a significant number of reports of jaw disease among its users. Despite an FDA review citing risks, says attorney Timothy M. O'Brien, Merck has yet to warn patients or issue a "Dear Doctor" letter to physicians, and continues to defend the drug in public statements. O'Brien argues that information gleaned from Merck files regarding the extent of a potential Fosamax public hazard should be made available to patients and physicians alike.
10 minute read
October 05, 2006 |

Fosamax: The Hiding of a Public Hazard

Since the release of Merck's blockbuster drug Fosamax, there have been a significant number of reports of jaw disease among its users. Despite an FDA review citing risks, says attorney Timothy M. O'Brien, Merck has yet to warn patients or issue a "Dear Doctor" letter to physicians, and continues to defend the drug in public statements. O'Brien argues that information gleaned from Merck files regarding the extent of a potential Fosamax public hazard should be made available to patients and physicians alike.
10 minute read
November 30, 2010 |

Largest PA Public Corporations

The following is a list of the largest public corporations in Pennsylvania as reported in the 2010 edition of PaLAW magazine.
43 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources

    • Creating a Culture of Compliance

      Brought to you by Ironclad

      Download Now

    • A Buyer's Guide to Law Firm Software

      Brought to you by PracticePanther

      Download Now

    • A Step-by-Step Flight Plan for Legal Teams: Fire Up Your Productivity Engine and Deliver High-Impact Work Faster

      Brought to you by HaystackID

      Download Now

    • Corporate Transparency Act Resource Kit

      Brought to you by Wolters Kluwer

      Download Now